MedTrace Logo

Improved Basophil Activation Test (BAT) in the Diagnostics of Drug Allergy

NCT03164044 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2018-12-17

No results posted yet for this study

Summary

Current study evaluates the use of the improved Basophil Activation Test (BAT) in the diagnostics of IgE-mediated allergy to antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs).

Conditions

  • Drug Allergy
  • Antibiotic Allergy
  • NSAID-Induced Anaphylactoid Reaction

Sponsors & Collaborators

  • The Republican Research and Practical Center for Epidemiology and Microbiology

    lead OTHER

Principal Investigators

  • Andrei Hancharou, Dr · Laboratory for Immunology and Cellular Biotechnology, The Republican Research and Practical Center for Epidemiology and Microbiology

  • Iryna U Ramanava · Laboratory for Immunology and Cellular Biotechnology, The Republican Research and Practical Center for Epidemiology and Microbiology

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-03
Primary Completion
2018-12-11
Completion
2019-06-30

Countries

  • Belarus

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03164044 on ClinicalTrials.gov